SRU Biosystems Announces Issuance of 20th Patent in the Field of Label-Free Optical Biosensors and Instrumentation

- Seven Additional Patents Allowed -

WOBURN, Mass.--(BUSINESS WIRE)--SRU Biosystems, a leader in highly sensitive labeled and label-free detection technologies, today announced the issuance of their 20^th patent in the field of label-free optical biosensors and instrumentation. The patent, US 7,264,973, includes claims specifically covering the label-free detection of cells on the Company’s optical biosensor. The patent adds to the expansive coverage that the Company has secured for its core technologies, including its instrumentation, microplate designs, and product applications.

“As part of our portfolio management, we will continue to seek worldwide protection for our innovative inventions in this exciting area.”

“The issuance of the 20^th patent, with an additional 7 patent applications that have been allowed, is part our ongoing strategy for the Company to protect its broad intellectual property in the field of optical biosensors,” said Richard Wagner, President and CEO of SRU Biosystems. “As part of our portfolio management, we will continue to seek worldwide protection for our innovative inventions in this exciting area.”

The patent is related to the SRU BIND® technology, including instrumentation, such as the BIND® Reader, capable of 96- and 384-well microplate detection. The SRU BIND® Reader can be easily integrated into automated systems and represents one of the most cost-effective solutions for high throughput label-free detection on the market for antibody and small molecule/fragment screening, and cell-based applications.

About SRU Biosystems

SRU Biosystems, Inc., is a life science company developing novel technologies for rapidly analyzing the interactions of large genomic, protein, peptide, antibody or small molecule compound libraries against a wide range of biochemical targets. SRU is incorporating its technology into microtiter plates, microarray slides and other industry standard formats to create sensitive and high throughput tools that can be used to answer important biological questions for biomedical research, pharmaceutical drug discovery and diagnostics. www.srubiosystems.com